| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,403 |
3,105 |
$295K |
| 92134 |
|
8,423 |
7,113 |
$131K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,800 |
2,450 |
$99K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,354 |
2,774 |
$76K |
| J7999 |
Compounded drug, not otherwise classified |
540 |
382 |
$15K |
| J0178 |
Injection, aflibercept, 1 mg |
19 |
12 |
$13K |
| J9035 |
Injection, bevacizumab, 10 mg |
422 |
297 |
$9K |
| 92250 |
|
312 |
260 |
$8K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
767 |
543 |
$5K |
| 2026F |
|
254 |
177 |
$95.89 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
20 |
14 |
$0.02 |
| 1036F |
|
737 |
515 |
$0.01 |
| G8482 |
Influenza immunization administered or previously received |
110 |
82 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
453 |
323 |
$0.00 |
| 2024F |
|
261 |
183 |
$0.00 |
| 2022F |
|
193 |
140 |
$0.00 |
| 5010F |
|
106 |
81 |
$0.00 |
| 4040F |
|
346 |
251 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
106 |
81 |
$0.00 |
| 99024 |
|
17 |
12 |
$0.00 |